$11.06
At close: Jun 12 EDT
$11.06
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Aardvark Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AARD | Benzinga
Aardvark Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS
$-0.710
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Aardvark Therapeutics using advanced sorting and filters.
Aardvark Therapeutics (AARD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Aardvark Therapeutics (AARD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Aardvark Therapeutics (NASDAQ:AARD) reporting earnings?
Aardvark Therapeutics (AARD) is scheduled to report earnings on August 14, 2025. The last reported earnings were for reported on May 14, 2025 for Q1.
What were the latest earnings per share (EPS) for Aardvark Therapeutics (NASDAQ:AARD)?
The Actual EPS was $-0.71, which missed the estimate of $0.00.
What were Aardvark Therapeutics’s (NASDAQ:AARD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
